• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境在结直肠癌中的作用及潜在治疗方法。

The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.

机构信息

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

出版信息

J Clin Lab Anal. 2022 Aug;36(8):e24585. doi: 10.1002/jcla.24585. Epub 2022 Jul 8.

DOI:10.1002/jcla.24585
PMID:35808903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9396196/
Abstract

BACKGROUND

Colorectal cancer (CRC) with a high prevalence is recognized as the fourth most common cause of cancer-related death globally. Over the past decade, there has been growing interest in the network of tumor cells, stromal cells, immune cells, blood vessel cells, and fibroblasts that comprise the tumor microenvironment (TME) to identify new therapeutic interventions.

METHODS

Databases, such as Google Scholar, PubMed, and Scopus, were searched to provide an overview of the recent research progress related to targeting the TME as a novel therapeutic approach.

RESULTS

Tumor microenvironment as a result of the cross talk between these cells may result in either advantages or disadvantages in tumor development and metastasis, affecting the signals and responses from the surrounding cells. Whilst chemotherapy has led to an improvement in CRC patients' survival, the metastatic aspect of the disease remains difficult to avoid.

CONCLUSIONS

The present review emphasizes the structure and function of the TME, alterations in the TME, its role in the incidence and progression of CRC, the effects on tumor development and metastasis, and also the potential of its alterations as therapeutic targets. It should be noted that providing novel studies in this field of research might help us to achieve practical therapeutic strategies based on their interaction.

摘要

背景

结直肠癌(CRC)的发病率较高,被认为是全球第四大常见的癌症相关死亡原因。在过去的十年中,人们对肿瘤细胞、基质细胞、免疫细胞、血管细胞和成纤维细胞组成的肿瘤微环境(TME)网络越来越感兴趣,以期找到新的治疗干预方法。

方法

通过 Google Scholar、PubMed 和 Scopus 等数据库搜索,提供了有关针对 TME 作为一种新的治疗方法的最新研究进展概述。

结果

这些细胞之间的相互作用导致肿瘤微环境可能在肿瘤的发展和转移中产生优势或劣势,影响周围细胞的信号和反应。虽然化疗已导致 CRC 患者的生存率提高,但该疾病的转移方面仍难以避免。

结论

本综述强调了 TME 的结构和功能、TME 的改变、其在 CRC 的发生和进展中的作用、对肿瘤发展和转移的影响,以及其改变作为治疗靶点的潜力。值得注意的是,在该研究领域提供新的研究可能有助于我们根据它们的相互作用实现实用的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/142efec7767d/JCLA-36-e24585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/c84361b49e01/JCLA-36-e24585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/06ede247ecf2/JCLA-36-e24585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/142efec7767d/JCLA-36-e24585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/c84361b49e01/JCLA-36-e24585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/06ede247ecf2/JCLA-36-e24585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb66/9396196/142efec7767d/JCLA-36-e24585-g004.jpg

相似文献

1
The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.肿瘤微环境在结直肠癌中的作用及潜在治疗方法。
J Clin Lab Anal. 2022 Aug;36(8):e24585. doi: 10.1002/jcla.24585. Epub 2022 Jul 8.
2
Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study.白藜芦醇抑制多细胞肿瘤微环境中结直肠癌细胞与基质细胞的串扰:体外和体内肿瘤微环境研究之间的桥梁。
Molecules. 2020 Sep 18;25(18):4292. doi: 10.3390/molecules25184292.
3
Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy.靶向“肿瘤微环境”:RNA 结合蛋白成为结直肠癌治疗的焦点。
Int Immunopharmacol. 2024 Apr 20;131:111876. doi: 10.1016/j.intimp.2024.111876. Epub 2024 Mar 16.
4
Friend or foe? The tumour microenvironment dilemma in colorectal cancer.敌友?结直肠癌细胞微环境的困境。
Biochim Biophys Acta Rev Cancer. 2017 Jan;1867(1):1-18. doi: 10.1016/j.bbcan.2016.11.001. Epub 2016 Nov 16.
5
Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.空间转录组图谱揭示结直肠癌中肿瘤相关成纤维细胞与肿瘤微环境成分的相互作用。
J Transl Med. 2022 Jul 6;20(1):302. doi: 10.1186/s12967-022-03510-8.
6
Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.成纤维细胞激活蛋白-α在结直肠癌细胞肿瘤微环境中的表达较为常见,可能成为一种治疗靶点。
Pathol Oncol Res. 2023 Aug 8;29:1611163. doi: 10.3389/pore.2023.1611163. eCollection 2023.
7
Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.鉴定与结直肠癌 5-氟尿嘧啶化疗相关的基因。
Front Immunol. 2022 Jun 17;13:887048. doi: 10.3389/fimmu.2022.887048. eCollection 2022.
8
Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions.揭示免疫的交响乐:通过免疫相互作用解码结直肠癌转移。
Front Immunol. 2024 Feb 13;15:1362709. doi: 10.3389/fimmu.2024.1362709. eCollection 2024.
9
The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.肿瘤微环境细胞在结直肠癌(CRC)恶病质中的作用。
Int J Mol Sci. 2021 Feb 4;22(4):1565. doi: 10.3390/ijms22041565.
10
Advances in Modeling the Immune Microenvironment of Colorectal Cancer.结直肠癌免疫微环境建模的研究进展。
Front Immunol. 2021 Feb 10;11:614300. doi: 10.3389/fimmu.2020.614300. eCollection 2020.

引用本文的文献

1
Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines.结直肠癌中的标志性基因突变:癌症疫苗的潜在新抗原
Int J Mol Sci. 2025 May 9;26(10):4559. doi: 10.3390/ijms26104559.
2
Characterizing macrophage diversity in colorectal malignancies through single-cell genomics.通过单细胞基因组学表征结直肠癌中的巨噬细胞多样性。
Front Immunol. 2025 Mar 21;16:1526668. doi: 10.3389/fimmu.2025.1526668. eCollection 2025.
3
Inhibiting HSP90 changes the expression pattern of PINK1 and BNIP3 and induces oxidative stress in colon cancer cells.

本文引用的文献

1
Inflammatory Microenvironment of Skin Wounds.皮肤伤口的炎症微环境。
Front Immunol. 2022 Mar 1;13:789274. doi: 10.3389/fimmu.2022.789274. eCollection 2022.
2
Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer.结直肠癌微环境中肿瘤免疫调节的分子机制。
Int J Mol Sci. 2022 Mar 3;23(5):2782. doi: 10.3390/ijms23052782.
3
Loss of NFE2L3 protects against inflammation-induced colorectal cancer through modulation of the tumor microenvironment.NFE2L3缺失通过调节肿瘤微环境对炎症诱导的结直肠癌起到保护作用。
抑制热休克蛋白90(HSP90)会改变帕金森病相关蛋白1(PINK1)和BCL2相互作用蛋白3(BNIP3)的表达模式,并在结肠癌细胞中诱导氧化应激。
Mol Biol Rep. 2025 Feb 8;52(1):212. doi: 10.1007/s11033-025-10303-x.
4
NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets.核因子-κB通路与血管生成:对结直肠癌发展及治疗靶点的见解
Eur J Med Res. 2024 Dec 19;29(1):610. doi: 10.1186/s40001-024-02168-w.
5
Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights.结直肠癌中免疫微环境与免疫细胞PAN凋亡的动态变化:最新进展与见解
Front Immunol. 2024 Nov 29;15:1502257. doi: 10.3389/fimmu.2024.1502257. eCollection 2024.
6
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression.黏着斑失活蛋白/MMP9 轴改变细胞外基质从而加速结直肠癌进展。
Nat Commun. 2024 Nov 30;15(1):10422. doi: 10.1038/s41467-024-54920-9.
7
Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort study.低CXCL11表达提示接受术前放化疗的直肠癌患者预后不良:一项回顾性队列研究
Virchows Arch. 2025 Apr;486(4):803-815. doi: 10.1007/s00428-024-03974-7. Epub 2024 Nov 27.
8
EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment.靶向 EpCAM 的桦木酸类似物纳米治疗改善结直肠肿瘤微环境中的治疗效果并诱导抗肿瘤免疫反应。
J Biomed Sci. 2024 Aug 20;31(1):81. doi: 10.1186/s12929-024-01069-8.
9
Predictors of response to immunotherapy in colorectal cancer.结直肠癌免疫治疗反应的预测因素。
Oncologist. 2024 Oct 3;29(10):824-832. doi: 10.1093/oncolo/oyae152.
10
Upregulation of EMR1 (ADGRE1) by Tumor-Associated Macrophages Promotes Colon Cancer Progression by Activating the JAK2/STAT1,3 Signaling Pathway in Tumor Cells.肿瘤相关巨噬细胞对EMR1(ADGRE1)的上调通过激活肿瘤细胞中的JAK2/STAT1,3信号通路促进结肠癌进展。
Int J Mol Sci. 2024 Apr 16;25(8):4388. doi: 10.3390/ijms25084388.
Oncogene. 2022 Mar;41(11):1563-1575. doi: 10.1038/s41388-022-02192-2. Epub 2022 Jan 28.
4
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma.白细胞介素-6/信号转导子和转录激活子3是肝细胞癌颇具前景的治疗靶点。
Front Oncol. 2021 Dec 15;11:760971. doi: 10.3389/fonc.2021.760971. eCollection 2021.
5
PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways.蛋白酶激活受体1(PAR1)和蛋白酶激活受体4(PAR4)通过信号转导和转录激活因子3(STAT3)及核因子κB(NF-κB)信号通路对食管鳞状细胞癌的肿瘤生长和转移发挥相反作用。
Cancer Cell Int. 2021 Nov 29;21(1):637. doi: 10.1186/s12935-021-02354-4.
6
The Role of miRNAs 340-5p, 92a-3p, and 381-3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem-Like Cell Study.miRNAs 340-5p、92a-3p 和 381-3p 在子宫内膜异位症患者中的作用:一项血浆和间充质干细胞样细胞研究。
Biomed Res Int. 2021 Sep 29;2021:5298006. doi: 10.1155/2021/5298006. eCollection 2021.
7
microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis.微小RNA作为子宫内膜异位症患者新型诊断生物标志物的系统评价与Meta分析
Expert Rev Mol Diagn. 2022 Apr;22(4):479-495. doi: 10.1080/14737159.2021.1960508. Epub 2021 Aug 13.
8
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.TGF-β 信号通路:从组织纤维化到肿瘤微环境。
Int J Mol Sci. 2021 Jul 15;22(14):7575. doi: 10.3390/ijms22147575.
9
Overexpression of TGF-β1 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration.宫颈癌相关成纤维细胞中 TGF-β1 和 SDF-1 的过表达促进细胞生长、侵袭和迁移。
Arch Gynecol Obstet. 2022 Jan;305(1):179-192. doi: 10.1007/s00404-021-06137-0. Epub 2021 Jul 1.
10
The Role of Cancer-Associated Fibroblasts in Tumor Progression.癌症相关成纤维细胞在肿瘤进展中的作用。
Cancers (Basel). 2021 Mar 19;13(6):1399. doi: 10.3390/cancers13061399.